VRXA (Veraxa Biotech Holding AG) Non Operating Income: $-0.98 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VRXA Veraxa Biotech Holding AG VRXA
6 GF Score
Price $1.50
! 3 Warning Signs
View Full Analysis

What is Veraxa Biotech Holding AG Non Operating Income?

Veraxa Biotech Holding AG VRXA -1.32% 6 Non Operating Income is $-0.98 Mil as of Dec. 2025. GuruFocus rates VRXA with a GF Score™ of 6/100. The stock has 3 warning signs investors should review.

Non Operating Income is income or expense that comes from miscellaneous sources. Veraxa Biotech Holding AG's Non Operating Income for the three months ended in Dec. 2025 was $0.00 Mil. Its Non Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.98 Mil.

Veraxa Biotech Holding AG Non Operating Income Related Terms

Veraxa Biotech Holding AG Non Operating Income Historical Data

* Premium members only.

The historical data trend for Veraxa Biotech Holding AG's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Veraxa Biotech Holding AG Non Operating Income Chart

Veraxa Biotech Holding AG Annual Data
Trend Dec23 Dec24 Dec25
Non Operating Income
0.00 0.00 0.00

Veraxa Biotech Holding AG Quarterly Data
Jun24 Dec24 Jun25 Dec25
Non Operating Income 0.00 0.00 0.00 0.00
VRXA
6GF Score
Veraxa Biotech Holding AG VRXA
Non Operating Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Veraxa Biotech Holding AG Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.

Non Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.98 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Non Operating Income →
What does a Non Operating Income of $-0.98 Mil mean?
Veraxa Biotech Holding AG (VRXA) has a Non Operating Income of $-0.98 Mil as of Dec. 2025. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on Veraxa Biotech Holding AG and its competitors.
Is Veraxa Biotech Holding AG's Non Operating Income too high?
Veraxa Biotech Holding AG's current Non Operating Income is $-0.98 Mil. Overall, Veraxa Biotech Holding AG has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Veraxa Biotech Holding AG's Non Operating Income compare to KRRO and CNXU?
Veraxa Biotech Holding AG's Non Operating Income of $-0.98 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Non Operating Income for a Biotechnology company?
A good Non Operating Income depends on the Biotechnology industry context. However, Non Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Non Operating Income mean?
A high Non Operating Income can signal that a stock is expensive relative to its fundamentals. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on Veraxa Biotech Holding AG and its competitors. Veraxa Biotech Holding AG's current Non Operating Income is $-0.98 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veraxa Biotech Holding AG stock overvalued right now?
Veraxa Biotech Holding AG (VRXA) has a current Non Operating Income of $-0.98 Mil. The current Non Operating Income is $-0.98 Mil. Veraxa Biotech Holding AG's overall GF Score™ is 6/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Non Operating Income calculated?
Non Operating Income is calculated from a company's financial statements. For Veraxa Biotech Holding AG (VRXA), the current Non Operating Income is $-0.98 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Veraxa Biotech Holding AG Business Description

Other Exchanges J8L0:Germany
Address Talacker 35, Zurich, CHE, 8001
Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.
6GF Score

Get the complete analysis for VRXA

Non Operating Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.50
Price